Allergy & Immunology billing · New York
Allergy and immunology billing services in New York carry a double burden — the nation's second-largest Medicaid program on one side and relentless white-bagging pressure on high-dollar biologics on the other — and 247MBS has managed both since 2005.
We file to the state's mainstream Medicaid managed-care plans through eMedNY, to traditional Medicare, and to every commercial carrier operating here, with a named account manager, a free 360° reporting dashboard, and HIPAA- and SOC 2 Type II-compliant workflows purpose-built for a specialty where the counted dose, not the visit, decides the month.
New York covers more than 6.4 million residents under Medicaid — a program second only to California — routed through mainstream managed-care plans on the eMedNY platform alongside a fee-for-service lane. For an allergy and immunology practice, the sharpest edge is white-bagging: carriers here keep steering expensive biologics toward specialty-pharmacy fulfillment rather than buy-and-bill, which rewrites how an omalizumab or mepolizumab claim is assembled and determines whether the drug revenue lands with your office or with the pharmacy. Making that call correctly, patient by patient, is a billing judgment as much as a clinical one.
| New York allergy billing at a glance | Detail |
|---|---|
| Medicaid program | New York Medicaid / DOH (eMedNY) |
| Delivery model | Mainstream Medicaid Managed Care + fee-for-service |
| Major plans | Fidelis Care (Centene), Healthfirst, MetroPlusHealth, Molina, UnitedHealthcare |
| Medicaid appeal window | 60 days (plan appeal) / 120 days (OTDA fair hearing) |
| Medicaid enrollment | ~6.4 million |
| Key challenge | White-bagging pressure on biologics; scale-driven testing-cap and 95165 dose exposure |
Scale is the second pressure. A busy Manhattan or Brooklyn allergy practice can log thousands of skin tests a month, and every one hinges on the per-test unit count and its plan's annual testing ceiling. Upstate offices in Buffalo, Rochester, and Syracuse answer to the same federal 95165 dose math — one cc per dose, ten doses per vial under Medicare — but underneath different commercial contracts. We settle the federal dose count and the plan-by-plan limits on the same claim, so nothing is left underbilled and nothing invites a takeback.
Because the revenue engine is the counted dose and the high-cost drug, we build each code to the way New York's payers actually adjudicate it:
| Code group | Codes | How New York adjudication is handled |
|---|---|---|
| Percutaneous & intracutaneous testing | 95004, 95024 | Charged one unit per individual test and kept within each plan's annual limit and the Medicare MUE — a large panel is that many units, never a single line |
| Antigen extract preparation | 95165 | Units read off the mixing log, one cc to a dose and ten doses per multidose vial under Medicare, matched to documentation on each claim |
| Injection administration | 95115, 95117 | 95117 filed a single time for two or more injections, and tied to the preparation charge only where our team compounded the extract |
| Severe-asthma & urticaria biologics | J-code HCPCS + JW / JZ | Milligram totals reconciled to the vial, wastage flagged with JW or JZ, and the buy-and-bill-versus-white-bag route plus prior auth settled before the drug is given |
| Same-day E/M with a procedure | Modifier 25 | Attached only when a separately documented evaluation genuinely stands apart from a scheduled testing or injection visit |
Testing revenue rests on the per-test count and the plan cap — file a broad panel as "1" and every workup shorts you. Preparation lives or dies on the 95165 dose rule, the specialty's most-audited line. Administration has to be kept distinct from preparation, with 95117 reported once no matter the injection count. And biologics pay only when the HCPCS math, the wastage modifier, and the authorization align — in New York, only when the buy-and-bill-versus-white-bag choice also matches plan policy.
Almost every leak comes back to a familiar few. We seal each one ahead of submission rather than fight it afterward:
95165 units estimated or billed per draw
Overpayment recoupment and False Claims Act exposure — the specialty's top audit target
Doses billed from the mixing log, one cc each and ten per vial, inside the 30-unit daily MUE
A broad skin panel entered as a single unit
Steady underpayment on every diagnostic workup
One unit per test, kept within each plan's annual cap
Biologic bought-and-billed where the plan mandates white-bag
Outright denial with no clean route to appeal
Buy-and-bill-versus-white-bag route verified against the plan before the drug is ordered
Biologic filed without JW/JZ or with wrong units
Claim returned unprocessable, wasted-drug recoupment
Milligrams given versus discarded reconciled, JW/JZ hard-stopped on every single-dose vial
95117 billed once for each injection
Overbilling edit and audit flag
95117 reported one time for two or more injections
Modifier 25 on a routine shot visit
Same-day E/M denial and a standing OIG audit theme
Modifier held back until a distinct, documented evaluation exists
Each of these is a decision made before the claim goes out, not an argument after it comes back. Request a Revenue Review and we'll show you which are landing on your remittances now.
Outsourcing earns its place in allergy because the entire margin is buried in rules a general biller rarely encounters — the 95165 dose definition, the ten-per-vial ceiling, the per-test skin count, the preparation-versus-administration split, and JW/JZ wastage on five-figure biologics. New York then adds the white-bagging call that must be right on every expensive drug. None of that carries over from an E/M-heavy book; it has to be learned on purpose. Concentrate it on one in-house desk inside a high-volume NYC or Albany office and the biggest-dollar claims freeze the week that person is away.
Move to us and you outsource allergy and immunology billing in New York as a standing capability rather than a staffing bet. A certified team fluent in dose counting and biologic buy-and-bill works your claims on a transaction-based fee, the audit-exposed lines are engineered to clear reconciliation every day, and a fixed salary with one point of failure gives way to a bench that never goes dark. For a practice where a single recouped vial or denied biologic can swamp a month of billing fees, outsourcing the work to a specialist team recovers its own cost fast.
Revenue review
A certified allergy billing specialist reviews your coding, unit counts, authorizations and aged A/R against the payers you actually bill in New York — and puts a number on what your current process is leaving on the table.
A allergy specialist will reach out within one business day.
A allergy specialist will reach out within one business day.
The right partner in this state already runs the specialty's audit-exposed lines as everyday work — not a general allergy and immunology billing company in New York that learns the rules on your claims. Our AAPC/AHIMA-certified coders pull every 95165 unit from your mixing log, set testing units to the number of tests performed, keep preparation and administration cleanly separated, and confirm each biologic authorization — and its buy-and-bill-versus-white-bag path — before the drug is administered.
It shows up on the remittance. Practices that shift their revenue cycle to us generally see denials drop by up to 40%, first-pass clean-claim rates near 99%, net collections around 99%, and days in A/R pulled under 25, with roughly nine of ten worked denials overturned on appeal. Claims are scrubbed and filed within 24 hours, and a 98% client-retention rate reflects results that repeat month after month. That is what professional allergy and immunology billing looks like when specialists own the New York cycle from charge capture to posting.
From a solo Manhattan allergist to a multi-site upstate immunology group, we run the whole cycle as one team instead of parceling it across vendors:
— testing units matched to the number of tests performed, 95165 doses billed straight from the preparation log, modifier 25 screened on every same-day E/M.
— coders who know the prep/admin split, the 95165 dose definition, and the JW/JZ wastage rules by heart.
— providers enrolled across New York's managed-care plans and Medicare, with biologic authorizations locked before administration.
— every denial traced to root cause and appealed inside the 60-day plan clock or the 120-day OTDA fair-hearing window.
— charge capture, 24-hour clean-claim submission, aged-A/R recovery, and posting across Medicaid, Medicare, and commercial payers on one dashboard.
Prefer to keep coding and billing under one roof? That is exactly the model — certified coders and billers on a single team reading a single record.
Coding shifts with the setting and the drug mix, and we bill each to the detail it demands:
buy-and-bill drugs where HCPCS units, wastage modifiers, and the white-bagging decision are the entire game.
Switching billers should not cost you a week of cash flow, and with us it won't. We run inside your current practice-management and EHR systems, so nobody relearns a platform. Credentialing and biologic prior-authorization review proceed alongside your live claim stream, a named account manager owns the transition from day one, and most New York allergy practices are fully live within a few weeks. Before the first claim goes out under our name, we reconcile your open A/R, map your managed-care and commercial payer mix and annual testing caps, and settle which biologics run buy-and-bill versus white-bag under each plan — so nothing already in flight slips through.
Medical billing for allergy and immunology in New York only works when the biller treats the 95165 antigen dose, the per-test skin panel, and the five-figure biologic as the separate, audit-exposed events they are — and knows the moment a plan's white-bagging rule rewrites the entire claim. As an outsourcing partner and medical billing services company built around that reality, we defend the margin on every antigen vial, testing unit, and prior authorization before the claim leaves your office — the line between a billing services company that merely drops claims and one that protects your revenue.
Each city page covers the local payer mix, the practices we bill for there, and the denials we prevent.
These are the New York markets we cover in depth. We bill allergy practices right across the state — tell us where you are and we will walk you through billing in your area.
Before any high-dollar drug is ordered, we verify whether the patient's plan requires buy-and-bill or specialty-pharmacy white-bag fulfillment, then build the claim to that policy. Matching it is what keeps a $30,000-a-year biologic from denying outright, and it decides whether the drug revenue stays with your practice or moves to the pharmacy.
Every dose is billed from your vial preparation and mixing log — one cc per dose, no more than ten doses from a multidose vial under Medicare, and always inside the daily unit edit. Since the units we submit equal the doses you documented, the claim survives the reconciliation an auditor runs against the mixing record.
Yes. Percutaneous and intradermal tests bill per individual test, so a broad panel is that many units rather than one, and we keep those units inside each payer's annual cap so they don't trip a frequency limit — essential when a Manhattan office runs thousands of tests a month.
That split sits at the center of allergy billing. We bill the antigen preparation code and the injection administration code as the two distinct services they are — together when your physician both compounded and injected, and administration alone when the vial was prepared elsewhere.
Yes. We submit to New York's mainstream managed-care plans and fee-for-service Medicaid through eMedNY, and we appeal denials inside the 60-day plan window and the 120-day OTDA fair-hearing window.
Yes. Certified coders and billers work together, so testing units, antigen dose counts, and claim submission stay aligned instead of being handed between two vendors.
Whether you are a solo practice or a multi-site group, we bill Allergy & Immunology across New York under one dedicated account manager and a live dashboard — and treat every counted unit, authorization and appeal as recoverable revenue until it is safely paid.
Prefer email? sales@247medicalbillingservices.com